Ionis Pharmaceuticals, Inc.
IONS
$43.03
$0.862.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.67% | -19.04% | -23.92% | 12.37% | -18.35% |
| Total Depreciation and Amortization | -3.66% | -3.58% | -2.26% | -6.61% | -4.21% |
| Total Amortization of Deferred Charges | -0.93% | 2.37% | 5.69% | 11.26% | 18.60% |
| Total Other Non-Cash Items | 23.19% | 32.85% | 24.68% | 382.77% | 345.32% |
| Change in Net Operating Assets | -7.11% | -202.53% | -171.02% | -11.47% | -2.76% |
| Cash from Operations | 33.36% | -55.13% | -62.90% | 34.89% | 24.12% |
| Capital Expenditure | -393.28% | -199.36% | -90.21% | 34.07% | 62.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -184.50% | -93.34% | 53.37% | -492.53% | 198.39% |
| Cash from Investing | -223.06% | -121.15% | 37.41% | -1,025.70% | 179.22% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | 34.25% | 90.85% | 90.85% | 99.97% | 85.57% |
| Issuance of Common Stock | 607.32% | 611.24% | 957.26% | 6,140.30% | 799.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -93.31% |
| Cash from Financing | 1,216.73% | 160.12% | -25.78% | 1.91% | -94.10% |
| Foreign Exchange rate Adjustments | 1,585.37% | -45.52% | -177.56% | -4.40% | -87.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.53% | -312.50% | -228.01% | -147.09% | -34.67% |